ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 1111

$2.01M Total Retail Price of All Prescriptions

Rank: 3 out of 1111

751 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 751 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 751 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 28,599 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 1,316 1,189 1 4
LISINOPRIL 1,066 1,033 2 2
FUROSEMIDE 1,054 970 3 6
NAMENDA 1,049 1,019 4 31
LEVOTHYROXINE SODIUM 1,031 990 5 3
DONEPEZIL HCL 974 943 6 25
HYDROCODONE-ACETAMINOPHEN 972 836 S3 7 1
SIMVASTATIN 793 718 8 5
CITALOPRAM HBR 688 630 9 14
RISPERIDONE 676 623 10 60
POTASSIUM CHLORIDE 659 624 11 9
AMLODIPINE BESYLATE 644 610 12 7
CYMBALTA 607 482 13 40
POLYETHYLENE GLYCOL 3350 602 508 14 45
DIVALPROEX SODIUM 599 543 15 82
LANTUS 418 379 16 46
KLOR-CON M20 417 376 17 79
WARFARIN SODIUM 406 351 18 19
QUETIAPINE FUMARATE 357 309 19 76
FAMOTIDINE 333 286 20 77
METOPROLOL TARTRATE 327 320 21 12
GABAPENTIN 316 262 22 10
SERTRALINE HCL 313 284 23 24
CARVEDILOL 304 299 24 21
ZOLPIDEM TARTRATE 287 262 25 16
ATORVASTATIN CALCIUM 276 256 26 15
CLOPIDOGREL 257 234 27 30
GLIPIZIDE 235 232 28 57
TRAZODONE HCL 230 209 29 32
TRAMADOL HCL 227 163 30 13
MIRTAZAPINE 225 186 31 52
METFORMIN HCL 224 196 32 8
TAMSULOSIN HCL 218 217 33 28
ESCITALOPRAM OXALATE 218 211 33 78
CLONIDINE HCL 214 195 35 42
OXYBUTYNIN CHLORIDE ER 213 199 36 114
HYDROCHLOROTHIAZIDE 209 195 37 11
LOSARTAN POTASSIUM 209 205 37 34
MELOXICAM 194 169 39 18
ALENDRONATE SODIUM 193 170 40 35
PRAVASTATIN SODIUM 192 188 41 17
LEVETIRACETAM 184 148 42 111
CARBIDOPA-LEVODOPA 177 169 43 101
DIGOXIN 175 169 44 47
PANTOPRAZOLE SODIUM 170 159 45 50
NOVOLOG 167 135 46 104
PLAVIX 166 146 47 49
OLANZAPINE 164 154 48 117
METOPROLOL SUCCINATE 158 155 49 20
ATENOLOL 146 112 50 22
LIDODERM 144 134 51 198
NYSTOP 142 93 52 175
NYSTATIN 141 117 53 151
AZITHROMYCIN 139 128 54 39
PROMETHAZINE HCL 138 99 R 55 69
FLUTICASONE PROPIONATE 138 123 55 27
LOPERAMIDE 133 122 57 165
NOVOLIN R 133 114 57 142
TRIAMCINOLONE ACETONIDE 128 118 59 128
ROPINIROLE HCL 125 125 60 68
IPRATROPIUM-ALBUTEROL 123 110 61 161
NITROFURANTOIN MONO-MACRO 119 110 62 149
CEPHALEXIN 118 102 63 89
AMIODARONE HCL 117 114 64 145
SEROQUEL 116 88 65 170
LYRICA 115 90 66 62
ARICEPT 114 112 67 352
TRAVATAN Z 111 111 68 183
TIZANIDINE HCL 107 51 69 91
FENTANYL 106 91 S2 70 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 101 70 71
ABILIFY 105 85 72 123
LATANOPROST 104 103 73 238
SANTYL 103 80 74 179
ALLOPURINOL 103 94 74 36
HALOPERIDOL 102 99 76 180
DIOVAN 98 94 77 51
ADVAIR DISKUS 97 90 78 43
OXYCONTIN 97 77 S2 78 106
CIPROFLOXACIN HCL 97 89 78 58
SPIRONOLACTONE 95 75 81 83
CYCLOBENZAPRINE HCL 94 63 R 82 37
SILVER SULFADIAZINE 93 47 83 261
BACLOFEN 85 0 84 119
MEGESTROL ACETATE 84 84 R 85 103
KLOR-CON M10 84 84 85 144
FINASTERIDE 83 82 87 115
MORPHINE SULFATE ER 83 58 S2 87 74
HYDROXYZINE HCL 83 72 R 87 159
DIVALPROEX SODIUM ER 82 61 90 171
PREDNISONE 81 71 91 48
OXYCODONE-ACETAMINOPHEN 77 59 S2 92 147
IBUPROFEN 76 72 93 66
EXELON 71 69 94 121
VENLAFAXINE HCL ER 71 61 94 105
NEXIUM 70 70 96 26
RANITIDINE HCL 70 57 96 29
SPIRIVA 69 52 98 53
PAROXETINE HCL 69 66 98 55
ISOSORBIDE MONONITRATE ER 68 68 100 73
DICYCLOMINE HCL 66 66 101 225
HYDRALAZINE HCL 66 57 101 155
LEXAPRO 66 64 101 208
FORTICAL 66 66 101 255
FLUOXETINE HCL 64 59 105 44
CARBAMAZEPINE 59 39 106 196
DILTIAZEM 24HR CD 58 58 107 152
TRIAMTERENE-HCTZ 57 47 108 80
BUSPIRONE HCL 57 49 108 96
LOVASTATIN 56 56 110 41
VOLTAREN 54 45 111 236
TORSEMIDE 53 53 112 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 53 112 23
ENOXAPARIN SODIUM 52 21 114 228
ALBUTEROL SULFATE 52 37 114 136
CHOLESTYRAMINE 51 47 116 291
SOTALOL 50 50 117 294
PHENYTOIN SODIUM EXTENDED 50 48 117 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.